|
|
|
|
DCT elements can be used to drive quantifiable financial ROI — but they need to be implemented strategically in order to achieve success. Gain a greater understanding how the right DCT solution, or combination of solutions, coupled with clear metrics and expert guidance on execution can demonstrate tangible, quantitative ROI in clinical trials.
|
|
|
|
|
Take a deep-dive into what goes into designing a successful clinical trial using DCT/hybrid elements — the quick answer? Strategic, patient-centered planning from day one — building-in operational efficiencies that accelerate trial timelines through increased patient enrollment and retention.
|
|
|
|
|
When faced with recruiting for complex trials, even the most seasoned sites can flounder. Strict inclusion/exclusion criteria, patient comorbidities, and multiple intensive site visits are just some of the barriers that impact recruitment efforts — leading to delays, extended timelines and even trial failures. By supporting sites, regardless of experiences, complex trials can meet enrollment targets and stay on schedule. Find out how.
|
|
|
|
|
|
|
If you missed MRN at the Clinical Leader Smart Sourcing: Patient Recruitment & Retention Showcase, this is your chance to catch MRN COO Todd McGrath speaking on the impact DCT/hybrid trial design can have on overall trial success. There is no "one-size-fits-all" — it takes an expertly tailored approach to achieve maximum results.
|
|
|
|
|
|
|
|
MRN At SCOPE Florida
|
MRN will be attending and presenting at SCOPE Florida in February 2026. As global leaders in patient & community-centric Decentralized Clinical Trials (DCTs), this is your opportunity to meet in-person with the MRN Team and learn how we can increase enrollment and engagement and accelerate your trial timelines by bringing your trials to more patients in more communities. Schedule a meeting time here, and visit us at Booth#1406.
|
|
|
